Skip to results
Modify your search
NARROW
1-10 of 10
Authors: Brad Poore
Journal Article
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_2, July 2021, Page ii15, https://doi.org/10.1093/noajnl/vdab070.060
Published: 05 July 2021
Journal Article
FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi.org/10.1093/noajnl/vdab024.081
Published: 25 March 2021
Journal Article
MBRS-63. THE ROLE OF THE SWI/SNF COMPLEX SUBUNIT SMARCD3 IN MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii409, https://doi.org/10.1093/neuonc/noaa222.567
Published: 04 December 2020
Journal Article
CSIG-21. BAF60C/SMARCD3 REGULATES TUMOR CELL DISSEMINATION IN MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii32, https://doi.org/10.1093/neuonc/noaa215.133
Published: 09 November 2020
Journal Article
LGG-09. PD-L1 EXPRESSION IN PEDIATRIC LOW GRADE GLIOMAS, AN OPPORTUNITY FOR INTERVENTION INDEPENDENT OF BRAF MUTATIONAL STATUS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii100, https://doi.org/10.1093/neuonc/noz036.152
Published: 23 April 2019
Journal Article
ATRT-04. UNBIASED METABOLIC PROFILING OF ATYPICAL TERATOID/RHABDOID TUMORS PREDICTS SENSITIVITY TO GLUTAMINE METABOLIC INHIBITORS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii63, https://doi.org/10.1093/neuonc/noz036.003
Published: 23 April 2019
Journal Article
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin Free
Neuro-Oncology, Volume 21, Issue 2, February 2019, Pages 252–263, https://doi.org/10.1093/neuonc/noy150
Published: 18 September 2018
Journal Article
LGG-51. METABOLIC PROFILING IN PEDIATRIC LOW GRADE GLIOMA IDENTIFIES GLUTATHIONE DEPLETION AFTER MTORC1 INHIBITION AND VALIDATES EVEROLIMUS AND CARBOPLATIN AS A POTENTIAL COMBINATION THERAPY Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i115, https://doi.org/10.1093/neuonc/noy059.392
Published: 22 June 2018
Journal Article
MBRS-61. IN VIVO METABOLOMICS REVEALS A POTENT COMBINATION THERAPY FOR MYC-DRIVEN MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i141, https://doi.org/10.1093/neuonc/noy059.505
Published: 22 June 2018
Journal Article
LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS Free
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv36, https://doi.org/10.1093/neuonc/nox083.148
Published: 31 May 2017
